Replies to post #1044 on Power 3 Medical Products Inc (fka PWRM)

[Tommy105]

Update of Power3 on their home page but now new stuff: http://www.power3medical.com/default.aspx

In November of 2009, Dr. Goldknopf was the Keynote speaker and Session Chair of the session entitled “Biomarkers and Diagnostics in Personalized Medicine” at the BIT International Congress and Exposition of Molecular Diagnostics (ICEMD 2009) meeting in Beijing, China.

Presently, through our collaboration with Transgenomic, Inc. the company is preparing to commercialize the Alzheimer’s disease diagnostic test and the Parkinson’s disease diagnostic test in Transgenomic’s CLIA certified lab in the first quarter of 2010, from which Power3 will receive milestone payments and Royalties. Power3 in 2009 had revenues of over $200,000 which included the license fee and operations support from Transgenomic, Inc.

The management of Power3 Medical Products, Inc. wishes to thank the many shareholders, investors and vendors who stepped up to the plate to provide Power3 the means to continue its mission to provide the world with new and better tools for the understanding and diagnostics of diseases to fulfill critical unmet needs. The management has worked exceedingly hard to sustain our progress during this economic down turn. We will continue to serve to the best of our ability for the science, the future of the company, and the shareholders. We feel blessed to be in this industry.


Helen R. Park, M.S.

Power3 Medical Products, Inc. CEO

[HOSS]

Yeah, and I have no doubt we will get it. The main point is that even if we seek FDA approval, which we will IMO, it will be a "rubber stamp"-like quick method, and not the long, drawn-out process. It should only take a month or two from filing for the approval, maybe less or a bit more.